BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11990861)

  • 1. Clinical features of psoriatic arthritis.
    Krueger GG
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S160-70. PubMed ID: 11990861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of psoriasis and psoriatic arthritis.
    Veale DJ; Ritchlin C; FitzGerald O
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii26-9. PubMed ID: 15708930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
    Ruderman EM
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S171-80. PubMed ID: 11990862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis: one or more diseases?
    Fitzgerald O; Dougados M
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):435-50. PubMed ID: 16777575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis and systemic inflammation: underdiagnosed enthesopathy.
    Girolomoni G; Gisondi P
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():3-8. PubMed ID: 19686379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
    Amital H; Barak V; Winkler RE; Rubinow A
    Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
    Radtke MA; Reich K; Blome C; Rustenbach S; Augustin M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):683-91. PubMed ID: 19309433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
    Krueger G; Callis K
    Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
    Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
    Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
    Gladman DD; Antoni C; Mease P; Clegg DO; Nash P
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii14-7. PubMed ID: 15708927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis update.
    Mease P
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):25-31. PubMed ID: 17121486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV
    J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard".
    Symmons DP; Lunt M; Watkins G; Helliwell P; Jones S; McHugh N; Veale D
    J Rheumatol; 2006 Mar; 33(3):552-7. PubMed ID: 16463433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis.
    Huemer C; Malleson PN; Cabral DA; Huemer M; Falger J; Zidek T; Petty RE
    J Rheumatol; 2002 Jul; 29(7):1531-5. PubMed ID: 12136915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriatic arthritis and arthroplasty: a review of the literature.
    lofin I; Levine B; Badlani N; Klein GR; Jaffe WL
    Bull NYU Hosp Jt Dis; 2008; 66(1):41-8. PubMed ID: 18333827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.